14-day Premium Trial Subscription Sign Up For FreeGet Free

Amarin Corporation PLC Stock Forecast NASDAQ:AMRN

$3.07 (-4.36%)

Volume: 4M

Closed: Jan 21, 2022

Hollow Logo Score: -1.786

Amarin Corporation PLC Stock Forecast

$3.07 (-4.36%)

Volume: 4M

Closed: Jan 21, 2022

Score Hollow Logo -1.786

Amarin Corporation PLC Company Profile

2 Pembroke House

Dublin 2

353 1 669 9020


Industry: Biotechnology

Sector: Healthcare

Amarin Corporation PLC


Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States. The company’s lead product includes Vascepa, a prescription-only omega-3 fatty acid capsule, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It is also involved in developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was founded in 1989 and is based in Dublin, Ireland.

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE